Welcome to our dedicated page for Cannae Holdings SEC filings (Ticker: CNNE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cannae Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cannae Holdings's regulatory disclosures and financial reporting.
Cannae Holdings (CNNE) reported a director equity grant. On 11/12/2025, a director acquired 7,818 shares of common stock at $0, reflecting a restricted stock award. Following the transaction, beneficial ownership stood at 32,753 shares, held directly.
The award vests in three equal annual installments beginning 11/12/2026, aligning compensation with multi‑year service. This filing documents insider equity compensation rather than an open‑market purchase.
Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock at $0 on 11/12/2025, reflecting a restricted stock grant.
Following the transaction, the reporting person beneficially owns 143,942 shares held directly. The grant vests in three equal annual installments beginning November 12, 2026.
Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock on 11/12/2025 as an “A” code transaction, reflecting a grant priced at $0. Following this award, the reporting person beneficially owned 207,437 shares directly.
The grant is described as restricted stock that will vest in three equal annual installments beginning November 12, 2026. The filing also lists 0 shares held indirectly via the Frank and Marisa Martire 2012 Florida Trust after the reported transaction.
Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock on 11/12/2025 at a reported price of $0, reflecting a restricted stock grant. Following the transaction, the director’s beneficial ownership stands at 28,818 shares.
The award vests in three equal annual installments beginning November 12, 2026, aligning compensation with longer-term service. This filing documents the grant and updated holdings; it does not indicate any open-market purchase or sale.
Cannae Holdings (CNNE) reported an insider equity award. A director received a grant of 7,818 shares of restricted stock on November 12, 2025 at $0. The award vests in three equal annual installments beginning November 12, 2026.
Following the grant, the director beneficially owns 34,733 shares directly. Indirect holdings include 1,942 shares through Holland III Family LP and 8,058 shares through the Malcolm Holland IRA.
Cannae Holdings, Inc. (CNNE) reported an insider equity grant. A director acquired 7,818 shares of common stock on 11/12/2025 at $0, coded as an acquisition (A).
The filing notes this was a grant of restricted stock that vests in three equal annual installments beginning November 12, 2026. Following this transaction, the director beneficially owns 66,853 shares, held directly.
Cannae Holdings (CNNE): Form 4 insider equity grant. A director received 15,635 shares of common stock as a restricted stock award on 11/12/2025 at $0. The award vests in three equal annual installments beginning November 12, 2026.
Following the transaction, beneficial ownership is reported as 1,008,235 shares direct and indirect holdings of 748,299 via Folco Development Corp., 236,011 via Foley Family Charitable Foundation, and 2,849,803 via Foley Family Enterprises LLC.
Cannae Holdings (CNNE) reported a director equity grant on a Form 4. On 11/12/2025, the reporting person acquired 23,453 shares of common stock at $0, identified as a grant of restricted stock.
Following the transaction, the director beneficially owns 62,356 shares, held directly. The grant vests in three equal annual installments beginning November 12, 2026.
Cannae Holdings (CNNE): Schedule 13G/A Amendment No. 1 filed by Newtyn Management, LLC. The filer reports beneficial ownership of 3,411,827 shares of common stock, representing 6.1% of the class as of September 30, 2025. The percentage is based on 56,014,815 shares outstanding as of August 8, 2025.
Holdings are through two funds managed by Newtyn: Newtyn TE Partners, LP with 2,120,341 shares and Newtyn Partners, LP with 1,291,486 shares. Newtyn, an investment adviser, reports sole voting and sole dispositive power over all 3,411,827 shares, with no shared power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control, consistent with a passive Schedule 13G filing.
Carronade Capital Master, LP and its affiliates are running a proxy contest at Cannae Holdings, Inc., seeking to elect four director nominees at the company’s 2025 annual shareholder meeting using a GOLD universal proxy card. Carronade has supplemented its definitive proxy statement and is actively campaigning through social media and a dedicated website. In a campaign video, Carronade criticizes Cannae’s share-price performance versus peers and asserts that Cannae’s leadership and board decisions have been costly for shareholders, urging investors to "put shareholders first" and vote GOLD for its slate.